F. Hoffmann-La Roche Ltd

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Roche to Buy Poseida Therapeutics for $1.5 Billion

Roche has entered into a definitive merger agreement to acquire Poseida Therapeutics, a US clinical-stage biopharmaceutical company developing donor-derived CAR-T cell therapies, in a deal valued at approximately $1.5 billion.

Roche to Acquire Obesity Drug Maker Carmot

In a move to participate in the race for anti-obesity drugs, Swiss pharma giant Roche has agreed to acquire Carmot Therapeutics, a privately owned US company based in Berkeley, California.

Roche to Acquire 100% Of Privately-held mtm Laboratories

Roche's Strong Pipeline Leaves Shareholders Optimistic

Alan Hippe to Leave ThyssenKrupp, Will Join Roche as CFO in April

Roche Maintains Focus as Industry Faces Cutbacks